Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient

被引:1
|
作者
Luisa Montes, Maria [1 ]
Maria Fraile, Jose [1 ]
Julian Gonzalez, Juan [1 ]
Ramon Arribas, Jose [1 ]
机构
[1] Hosp Univ La Paz, Med Interna Serv, Madrid, Spain
来源
关键词
D O I
10.1016/j.eimc.2008.02.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:60 / 61
页数:2
相关论文
共 50 条
  • [1] Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects
    Genebat, Miguel
    Vera, Francisco
    Hernandez-Quero, Jose
    Domingo, Pere
    Guardiola, Jose M.
    Martinez-Madrid, Onofre
    Martinez, Lorena
    Garcia de la Liana, Francisco
    Sanchez-Villegas, Jorge
    Alvarez, Hortensia
    Marino, Ana
    Lluch, Jose F.
    Martinez-Perez, Maria A.
    Marin, Jorge
    Ruiz-Mateos, Ezequiel
    Leal, Manuel
    [J]. ANTIVIRAL RESEARCH, 2014, 104 : 59 - 61
  • [2] SVR in HIV-HCV coinfected patients can be enhanced by optimizing dosing of pegylated interferon and ribavirin therapy
    Monto, Alexander
    Rodriguez, Rebecca F.
    Currie, Sue
    George, Sally
    Lee, Natalie
    Tracy, Daniel P.
    Wright, Teresa L.
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A794 - A794
  • [3] Efficacy and safety of interferon and ribavirin therapy in HIV-HCV coinfected patients
    Zylberberg, H
    Benhamou, Y
    Chaix, ML
    Fontaine, H
    Rouzioux, C
    Katlama, C
    Poynard, T
    Bréchot, C
    Pol, S
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 : 178 - 178
  • [4] Hcv dynamics in HIV/HCV coinfected patients treated with pegylated interferon and ribavirin.
    Talal, AH
    Shata, MT
    Flynn, SM
    Dorante, G
    Laughlin, M
    Ribeiro, RM
    Perelson, AS
    [J]. HEPATOLOGY, 2002, 36 (04) : 205A - 205A
  • [5] Predictive value of early virological response (12 weeks) to pegylated interferon plus ribavirin in HIV-HCV coinfected patients
    Perez-Olmeda, M
    Martin-Carbonero, L
    Romero, M
    Rios, P
    Nunez, M
    Soriano, V
    Garcia-Samaniego, J
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 163 - 163
  • [6] Management of the HIV-HCV coinfected patient
    Mutimer, D
    [J]. GUT, 2000, 47 (05) : 608 - 609
  • [7] Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia
    Mira, J. A.
    Neukam, K.
    Lopez-Cortes, L. F.
    Rivero-Juarez, A.
    Tellez, F.
    Giron-Gonzalez, J. A.
    de los Santos-Gil, I.
    Ojeda-Burgos, G.
    Merino, D.
    Rios-Villegas, M. J.
    Collado, A.
    Torres-Cornejo, A.
    Macias, J.
    Rivero, A.
    Perez-Perez, M.
    Pineda, J. A.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (09) : 1879 - 1884
  • [8] Autoimmune hemolytic anemia in HCV/HIV coinfected patients during treatment with pegylated alpha-2a interferon plus ribavirin
    Vilar, Fernando Crivelenti
    de Castro, Gleusa
    Moya, Maria Janete
    Candolo Martinelli, Ana de Lourdes
    De Santis, Gil Cunha
    Nunes da Cunha Cozac, Ana Paula Costa
    de Castro Figueiredo, Jose Fernando
    [J]. REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2007, 40 (06) : 678 - 680
  • [9] Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia
    J. A. Mira
    K. Neukam
    L. F. López-Cortés
    A. Rivero-Juárez
    F. Téllez
    J. A. Girón-González
    I. de los Santos-Gil
    G. Ojeda-Burgos
    D. Merino
    M. J. Ríos-Villegas
    A. Collado
    A. Torres-Cornejo
    J. Macías
    A. Rivero
    M. Pérez-Pérez
    J. A. Pineda
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2015, 34 : 1879 - 1884
  • [10] ANTIRETROVIRALS REDUCE RIBAVIRIN EXPOSURE IN HIV-HCV COINFECTED PATIENTS
    Quioc, Jean-Jacques
    Jullien, Vincent
    Mallet, Vincent
    Nalpas, Bertrand
    Pol, Stanislas
    [J]. HEPATOLOGY, 2008, 48 (04) : 874A - 874A